{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:12:02Z","timestamp":1780053122710,"version":"3.54.0"},"reference-count":19,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>An 81-year-old woman with follicular lymphoma treated with obinutuzumab and bendamustine developed cognitive impairment and dysarthria. Three months before death, neurological exams showed dysarthria, right hemiparesis, and gait disturbance. Blood tests showed lymphocytopenia (lymphocyte 10.4%). Cerebrospinal fluid (CSF) findings were unremarkable, including with respect to cytology. Brain MRI demonstrated a mass-like hyperintense lesion in the left parietal lobe and band-like abnormalities in the left fronto-temporal white matter that lacked contrast enhancement. Symptoms progressed to hemiplegia and mutism; severe dysphagia eventually necessitated intravenous fluid management. Follow-up MRI one month before death revealed a lesion encompassing nearly the entire left hemisphere, with hyperperfusion observed during arterial spin labeling (ASL). JC virus was detected in CSF (221 copy\/mL), confirming that the patient had progressive multifocal leukoencephalopathy (PML). Subsequently, she exhibited poor arousal, followed by death. Here, lymphoma recurrence or PML was suspected due to a post-chemotherapy unilateral expanding brain lesion. These conditions are usually differentiated by contrast-enhancement patterns, but PML can also enhance during immune reconstitution. Moreover, lesions rarely cause a mass effect and more often exhibit hyperperfusion, which may aid in diagnosis. While unilateral PML has been reported, especially in the early stage, such an extensive lesion involving nearly an entire single hemisphere, as seen in our case, is rare.<\/jats:p>","DOI":"10.3390\/reports9020170","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:06:56Z","timestamp":1780049216000},"page":"170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progressive Multifocal Leukoencephalopathy or Lymphoma? A Massive Unilateral Hemispheric Mimicker in a Patient Undergoing Lymphoma Treatment"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-0913","authenticated-orcid":false,"given":"Koji","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Fukui General Hospital, 55-16-1 Egami-cho, Fukui 910-8561, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-9743","authenticated-orcid":false,"given":"Mamiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Fukui General Hospital, 55-16-1 Egami-cho, Fukui 910-8561, Japan"},{"name":"Graduate School of Health Science, Fukui Health Science University, 55-13-1 Egami-cho, Fukui 910-3190, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Fukui Hospital, 23-3 Matsuoka Shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2010-9567","authenticated-orcid":false,"given":"Eiju","family":"Negoro","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Fukui Hospital, 23-3 Matsuoka Shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Fukui Hospital, 23-3 Matsuoka Shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"ref_2","unstructured":"Genentech Inc. (2026, April 27). GAZYVA (Obinutuzumab) Injection, for Intravenous Use: Prescribing Information, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/125486s037s038lbl.pdf."},{"key":"ref_3","unstructured":"(2026, April 27). Co-Ordination Group for Mutual Recognition and Decentralised Procedures\u2014Human (CMDh). Bendamustine Hydrochloride: Scientific Conclusions and Grounds for the Variation to the Terms of the Marketing Authorisation(s). European Medicines Agency. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/psusa\/bendamustine-hydrochloride-cmdh-scientific-conclusions-and-grounds-variation-amendments-product-information-and-timetable-implementation-psusa00003162202001_en.pdf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1212\/WNL.0000000000207622","article-title":"Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy","volume":"101","author":"Schweitzer","year":"2023","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/brain\/awab419","article-title":"The neuroradiology of progressive multifocal leukoencephalopathy: A clinical trial perspective","volume":"145","author":"Baldassari","year":"2022","journal-title":"Brain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1007\/s11604-025-01837-y","article-title":"Overview of MRI findings in progressive multifocal leukoencephalopathy","volume":"43","author":"Mori","year":"2025","journal-title":"Jpn. J. Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Quintanilla-Bord\u00e1s, C., Gorriz, D., Cubas-N\u00fa\u00f1ez, L., Castillo-Villalba, J., Carreres-Polo, J., Casanova, B., and P\u00e9rez-Miralles, F.C. (2024). Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: A case report. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1465678"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"De Masi, R., Orlando, S., Armenise, S., Spagnolo, P., Capra, R., and Costa, M.C. (2022). Changes in Brain Volumes Are Relevant during Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: Lessons from a Case Report. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113642"},{"key":"ref_9","first-page":"10","article-title":"Progressive multifocal leukoencephalopathy: A case report in an immunocompetent patient","volume":"8","author":"Faceira","year":"2018","journal-title":"Adv. Infect. Dis."},{"key":"ref_10","unstructured":"Wattjes, M.P. (2019). The Role of MRI in Pharmacovigilance of Natalizumab-Treated MS Patients: A \u201cKnown Unknown\u201d?. [Ph.D. Thesis, Vrije Universiteit Amsterdam]."},{"key":"ref_11","first-page":"301","article-title":"A unilateral large demyelinating lesion in the cerebral white matter with slowly progressive hemiplegia and intrathecal JC virus antibody production","volume":"33","author":"Nishimura","year":"1993","journal-title":"Rinsho Shinkeigaku"},{"key":"ref_12","first-page":"e91491","article-title":"A case report of progressive multifocal leukoencephalopathy (PML) in an immunocompetent patient","volume":"17","author":"Nazneen","year":"2025","journal-title":"Cureus"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13365-011-0045-2","article-title":"Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS","volume":"17","author":"McGuire","year":"2011","journal-title":"J. Neurovirol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e20240001","DOI":"10.1590\/0100-3984.2024.0001","article-title":"Hyperintense lesions of the middle cerebellar peduncle and beyond: A pictorial essay","volume":"57","author":"Tamanini","year":"2025","journal-title":"Radiol. Bras."},{"key":"ref_15","first-page":"23","article-title":"Progressive multifocal leukoencephalopathy","volume":"137","author":"Alstadhaug","year":"2017","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1093\/brain\/awt268","article-title":"Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome","volume":"136","author":"Khoury","year":"2013","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e209874","DOI":"10.1212\/WNL.0000000000209874","article-title":"Global hyperperfusion in the brain at onset of the immune reconstitution inflammatory syndrome in a patient with natalizumab-associated PML","volume":"103","author":"Yokote","year":"2024","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kimura, K., Hayashi, K., Sato, M., Nakaya, Y., Suzuki, A., Takaku, N., Hayashi, H., Hayashi, K., Miura, T., and Kobayashi, Y. (2025). Hyperperfusion improvement: A potential therapeutic marker in neuromyelitis optica spectrum disorder (NMOSD). Diagnostics, 15.","DOI":"10.3390\/diagnostics15212723"},{"key":"ref_19","first-page":"e45815","article-title":"Progressive Multifocal Leukoencephalopathy Presenting as Primary CNS Malignancy in an Immunocompetent Patient","volume":"15","author":"Truong","year":"2023","journal-title":"Cureus"}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/2\/170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:43:58Z","timestamp":1780051438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/2\/170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["reports9020170"],"URL":"https:\/\/doi.org\/10.3390\/reports9020170","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}